About Kintsugi Therapeutics

Kintsugi Therapeutics is a preclinical biopharmaceutical company that specializing in the development of therapies for the treatment of liver conditions and other pathologies. They also develop ER stress inhibitor for the treatment of liver disease.

Company Highlights
Year Founded

2019

icon-altEmployees

3

Location (HQ)

ESP

Since Last Funding

2 years 10 months

icon-altTotal Investment Amt

$1.1M

Last Funding Round

Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology Research

Pharmaceutical